参考文献
(在框内滑动手指即可浏览)
[1] Maurer CA, Renzulli P, Kull C, et al. The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: long-term results [J]. Ann Surg Oncol, 2011, 18(7): 1899-1906.
[2] den Dulk M, Krijnen P, Marijnen CA, et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy [J]. Eur J Cancer, 2008, 44(12): 1710- 1716.
[3] Bernardshaw SV, Ovrebo K, Eide GE, et al. Treatment of rectal cancer: reduction of local recurrence after the introduction of TME - experience from one university hospital [J]. Dig Surg, 2006, 23(1-2): 51- 59.
[4] Folkesson J, Birgisson H, Pahlman L, et al. Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate [J]. J Clin Oncol, 2005, 23(24): 5644- 5650.
[5] van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial [J]. Lancet Oncol, 2011, 12(6): 575- 582.
[6] Kodeda K, Johansson R, Zar N, et al. Time trends, improvements and national auditing of rectal cancer management over an 18- year period [J]. Colorectal Dis, 2015, 17(9): 168-179.
[7] Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors [J]. Prz Gastroenterol, 2019, 14(2): 89-103.
[8] Camilleri-Brennan J, Steele RJ. The impact of recurrent rectal cancer on quality of life [J]. Eur J Surg Oncol, 2001, 27(4): 349-353.
[9] Kodeda K, Derwinger K, Gustavsson B, et al. Local recurrence of rectal cancer: a population-based cohort study of diagnosis, treatment and outcome [J]. Colorectal Dis, 2012, 14(5): 230-237.
[10] Denost Q, Faucheron JL, Lefevre JH, et al. French current management and oncological results of locally recurrent rectal cancer [J]. Eur J Surg Oncol, 2015, 41(12): 1645- 1652.
[11] Hagemans JAW, van Rees JM, Alberda WJ, et al. Locally recurrent rectal cancer; long-term outcome of curative surgical and non- surgical treatment of 447 consecutive patients in a tertiary referral centre [J]. Eur J Surg Oncol, 2020, 46(3): 448- 454.
[12] Jankowski M, Las-Jankowska M, Rutkowski A, et al. Clinical reality and treatment for local recurrence of rectal cancer: a single-center retrospective study [J]. Medicina (Kaunas), 2021, 57(3): 286.
[13] Matsuyama T, Yamauchi S, Masuda T, et al. Treatment and subsequent prognosis in locally recurrent rectal cancer: a multicenter retrospective study of 498 patients [J]. Int J Colorectal Dis, 2021, 36(6): 1243-1250.
[14] Tashiro J, Fujii M, Masaki Y, et al. Surgical outcomes of hybrid hand-assisted laparoscopic pelvic exenteration for locally advanced rectal cancer: initial experience [J]. Asian J Endosc Surg, 2020,14(2): 213-222
[15] Kim SY, Kwak HD, Kim SH. Emerging role of the robot in rectal cancer surgery [J]. ANZ J Surg 2015, 85(4): 205e6.
[16] Simillis C, Hompes R, Penna M, et al. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? [J].Colorectal Dis, 2016, 18(1): 19e36.
[17] D'Andrea AP, McLemore EC, Bonaccorso A, et al. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve [J]. Surg Endosc, 2020, 34(9): 4101e9.
[18] Smith N, Murphy DG, Lawrentschuk N, et al. Robotic multivisceral pelvic resection: experience from an exenteration unit [J]. Tech Coloproctol, 2020, 24(11): 1145e53.
[19] Commins I, McCormick J, Smart P, et al. Advanced applications of transanal total mesorectal excision (taTME): beyond taTME planes (a cohort study) [J/OL]. Ann Laparosc Endosc Surg, 2020,5,(2020-10-20)[2022-10-20].http://dx./10.21037/ales-2019-tatme-10
[20] Kumar NA, Sasi SP, Shinde RS, et al. Minimally invasive surgery for pelvic exenteration in primary colorectal cancer [J]. J Soc Laparoendosc Surg, 2020, 24(3): e2020.00026.
[21] 左明, 旷天立, 庄翔, 等.24例直肠癌术后局部复发的诊治[J]. 四川肿瘤防治, 1996, 9(4): 41- 43.
[22] 鲍学斌, 杜绍先, 张 斌, 等. 局部复发性直肠癌的再手术治疗 [J]. 中国实用外科杂志.1999.19(6): 356-357.
[23] Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability [J]. Dis Colon Rectum, 2004, 47(10): 1599-1606.
[24] 岳爱民, 谢振斌, 王简. 直肠癌术后局部复发再手术27例临床分析[J].江苏医药,2004, 9(30): 715.
[25] 黄伟民 孙团起 张东坤. 直肠癌术后局部复发的再手术 [J]. 中国实用外科杂志, 2002, 22(2): 103-105.
[26] Harris CA , Solomon MJ , Heriot AG ,et al. The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer [J]. Ann Surg, 2016, 264(2): 323-329.
[27] PelvEx Collaborative. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer [J]. Br J Surg, 2018, 105(6): 650-657.
[28] Westberg K, Palmer G, Hjern F, et al. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer [J]. Br J Surg, 2019, 106(6): 790-798.
[29] 陈功. 直肠癌局部复发的多学科综合诊治进展[J]. 中国普外基础与临床杂志. 2013, 20 (11): 1208-1216.
[30] Bouchard P, Efron J. Management of recurrent rectal cancer[J]. Ann Surg Oncol, 2010, 17(5): 1343- 1356.
[31] Pacelli F, Tortorelli AP, Rosa F, et al. Locally recurrent rectal cancer: prognostic factors and long-term out comes of multimodal therapy[J]. Ann Surg Oncol, 2010, 17(1): 152-162.
[32] 张安平, 刘宝华. 直肠癌局部复发的综合治疗[J]. 中国普外基础与临床杂志, 2014, 11 (21): 1344-1348.
[33] Hasegawa S, Kajitani R, Matsumoto Y, et al. Combined laparoscopic and transperineal endoscopic total pelvic exenteration for local recurrence of rectal cancer [J]. Tech Coloproctol, 2020, 24(6): 599- 601.